Literature DB >> 18378863

Susceptibility to depression expressed as alterations in cortisol day curve: a cross-twin, cross-trait study.

Marieke C Wichers1, Inez Myin-Germeys, Nele Jacobs, Gunter Kenis, Catherine Derom, Robert Vlietinck, Philippe Delespaul, Ron Mengelers, Frenk Peeters, Nancy Nicolson, Jim Van Os.   

Abstract

OBJECTIVE: To examine, using a cross-twin cross-trait design, the hypotheses 1) that the genetic and environmental susceptibility to depression is expressed, in part, as alterations in cortisol day curves and 2) that cortisol abnormalities are not merely the consequence of depressive states or the stressors associated with its onset. Alteration of diurnal secretion of cortisol is a possible endophenotype of depression, as depressed patients show alterations in cortisol dynamics over the day.
METHODS: Salivary cortisol measurements were obtained in a sample of 279 twin pairs at 10 random times a day for 5 days. A structured clinical interview for DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition) axis I mood disorder (SCID) was administered. Using multilevel regression analysis, the moderating influence of a lifetime diagnosis of depression in the co-twin on the association between time of day and cortisol concentrations in the proband twin was examined.
RESULTS: Diurnal variation in cortisol in the proband twin differed as a function of lifetime diagnosis of depression in the co-twin. In addition, this moderating effect was significantly stronger for dizygotic than for monozygotic twins.
CONCLUSIONS: Probands of co-twins with lifetime depression have a different diurnal cortisol profile than those without, suggesting that altered hypothalamic-pituitary-adrenal axis functioning is an indicator of depression susceptibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378863     DOI: 10.1097/PSY.0b013e31816b1eee

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  9 in total

1.  Specific medical conditions associated with clinically significant depressive symptoms in men.

Authors:  Evan Atlantis; Kylie Lange; Robert D Goldney; Sean Martin; Matthew T Haren; Anne Taylor; Peter D O'Loughlin; Villis Marshall; Wayne Tilley; Gary A Wittert
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-10-26       Impact factor: 4.328

2.  Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression.

Authors:  Nina C Donner; Christian D Montoya; Jodi L Lukkes; Christopher A Lowry
Journal:  Psychoneuroendocrinology       Date:  2011-09-15       Impact factor: 4.905

3.  Cortisol and depressive symptoms in a population-based cohort of midlife women.

Authors:  Jennifer M Knight; Elizabeth F Avery; Imke Janssen; Lynda H Powell
Journal:  Psychosom Med       Date:  2010-09-14       Impact factor: 4.312

4.  A cluster analytic approach to examining the role of cortisol in the development of post-traumatic stress and dysphoria in adult traumatic injury survivors.

Authors:  Devi Jayan; Terri A deRoon-Cassini; Garrett Sauber; Cecilia J Hillard; Jacklynn M Fitzgerald
Journal:  Psychoneuroendocrinology       Date:  2021-10-15       Impact factor: 4.905

5.  Longitudinal mediators of a randomized prevention program effect on cortisol for youth from parentally bereaved families.

Authors:  Linda J Luecken; Melissa J Hagan; Irwin N Sandler; Jenn-Yun Tein; Tim S Ayers; Sharlene A Wolchik
Journal:  Prev Sci       Date:  2014-04

6.  Traits of fear resistance and susceptibility in an advanced intercross line.

Authors:  Jennifer L McGuire; Hadley C Bergstrom; Clarissa C Parker; Thien Le; Maria Morgan; Haiying Tang; Reed G Selwyn; Afonso C Silva; Kwang Choi; Robert J Ursano; Abraham A Palmer; Luke R Johnson
Journal:  Eur J Neurosci       Date:  2013-08-22       Impact factor: 3.386

7.  Testing an mHealth momentary assessment Routine Outcome Monitoring application: a focus on restoration of daily life positive mood states.

Authors:  Jim van Os; Philippe Delespaul; Daniela Barge; Roberto P Bakker
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

8.  Cortisol awakening response is linked to disease course and progression in multiple sclerosis.

Authors:  Simone Kern; Ivonne Krause; Antje Horntrich; Katja Thomas; Julia Aderhold; Tjalf Ziemssen
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Evidence that a psychopathology interactome has diagnostic value, predicting clinical needs: an experience sampling study.

Authors:  Jim van Os; Tineke Lataster; Philippe Delespaul; Marieke Wichers; Inez Myin-Germeys
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.